The Cannabis plant has been known for centuries for the medicinal properties of its extracts. As extensive research into its effectiveness as a beneficial therapy for treating chronic diseases or other medical conditions rapidly advances, an interesting approach has been developed to isolate pure fractions of Cannabinoids using Fast Centrifugal Partitioning Chromatography (FCPC).
The process was optimized for methanol extracts containing a mixture of Tetrahydrocannabinol (THC), Cannabidiol (CBD), and Cannabigerol (CBG) and respective isomers. Due to the selective partitioning nature and discrete stage-wise operation of the FCPC device, pure fractions of the constituents with very similar molecular structures can be obtained in semi-preparative, preparative, and production quantities.